Statistics
Publications
42
Citations
4.6K
H-Index
28
Active since
1990
Paul Cheng is an author at Stanford University specializing in medicine, cell biology, and cell signaling.
Publications per year
1990–2024
42
42
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Frederick L. Locke, David B. Miklos, Caron A. Jacobson et al. · New England Journal of Medicine · 2021 · 1.4K citations · Full text
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
Jason R. Westin, Olalekan O. Oluwole, Marie José Kersten et al. · New England Journal of Medicine · 2023 · 359 citations · Full text
Grant Duffy, Paul Cheng, Neal Yuan et al. · JAMA Cardiology · 2022 · 194 citations · Full text
1–5 of 42